Literature DB >> 1371035

Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications.

R W Kass1, M N Kotler, S Yazdanfar.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1371035     DOI: 10.1016/0002-8703(92)90665-i

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  7 in total

1.  Techniques to enhance extramyocardial collateral blood flow after a cardiomyoplasty.

Authors:  J D Mannion; M Magno; P Buckman; W Bailey; V Blood; T Heiman-Patterson; R N Edie; F E Rosato
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

Review 2.  Coronary arterial calcification as an active process: a new perspective on an old problem.

Authors:  T M Doherty; R C Detrano
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

3.  New collateral flow increasing early after coronary occlusion prevented myocardial necrosis in dogs.

Authors:  S Nakai; K Ishikawa; I Ogawa; H Koka; N Kamata; H Akiyama; R Katori
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

4.  Coronary collateral vessel development after acute myocardial infarction.

Authors:  Ersan Tatli; Armađan Altun; Mutlu Büyüklü; Ahmet Barotçu
Journal:  Exp Clin Cardiol       Date:  2007

Review 5.  Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.

Authors:  W Linz; G Wiemer; J Schaper; R Zimmermann; K Nagasawa; P Gohlke; T Unger; B A Schölkens
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

6.  MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway.

Authors:  Guo-Hua Dai; Pei-Ze Ma; Xian-Bo Song; Ning Liu; Tong Zhang; Bo Wu
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

7.  Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression.

Authors:  Guo-Hua Dai; Ning Liu; Jing-Wei Zhu; Jing Yao; Chun Yang; Pei-Ze Ma; Xian-Bo Song
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-15       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.